SCOPUS 정보 검색 플랫폼

Journal of Family Practice

Volumn 55, Issue 8, 2006, Pages 707-708

Which medications can be split without compromising efficacy and safety?

(3) Noviasky, John a Lo, Vincent b,c Luft, Diane D b

a St Elizabeth Medical Center (United States)

b SUNY UPSTATE MEDICAL UNIVERSITY (United States)

c SAN JOAQUIN GENERAL HOSPITAL (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ATORVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCHLOROTHIAZIDE; LISINOPRIL; METOPROLOL; MEVINOLIN; SIMVASTATIN; TRIACYLGLYCEROL; WARFARIN;

ACCURACY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COGNITION; COST CONTROL; DRUG EFFICACY; DRUG MANUFACTURE; DRUG SAFETY; DYSLIPIDEMIA; ENTERIC COATED TABLET; EVALUATION; EVIDENCE BASED MEDICINE; HEALTH CARE FACILITY; HUMAN; HYPERTENSION; OFF LABEL DRUG USE; PATIENT COMPLIANCE; POLICY; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; VISUAL ACUITY; DRUG COST; DRUG FORMULATION; ECONOMICS; TABLET;

CLINICAL TRIALS; COST SAVINGS; DRUG COMPOUNDING; DRUG COSTS; HUMANS; TABLETS;

EID: 33750697621 PISSN: 00943509 EISSN: None Source Type: Journal
DOI: None Document Type: Review

Times cited : (22)

References (8)

1
- 0002183643
- Evaluation of tablet-splitting in patients taking lisinopril for hypertension
- Rindone JP. Evaluation of tablet-splitting in patients taking lisinopril for hypertension. J Clin Outcomes Management 2000; 7:22-24.
- (2000) J Clin Outcomes Management , vol.7 , pp. 22-24
- Rindone, J.P.¹

2
- 20444480876
- Effect of splitting simvastatin tablets for control of low-density lipoprotein cholesterol
- Parra D, Beckey NP, Raval HS, et al. Effect of splitting simvastatin tablets for control of low-density lipoprotein cholesterol Am J Cardiol 2005; 95:1481-1483.
- (2005) Am J Cardiol , vol.95 , pp. 1481-1483
- Parra, D.¹ Beckey, N.P.² Raval, H.S.³

3
- 3242746174
- Effects of tablet-splitting program in patients taking HMG-Coa reductase inhibitors: Analysis of clinical effects, patient satisfaction, compliance, and cost avoidance
- Gee M, Hasson NK, Hahn T, Ryono R. Effects of tablet-splitting program in patients taking HMG-Coa reductase inhibitors: analysis of clinical effects, patient satisfaction, compliance, and cost avoidance. J Managed Care Pharm 2002; 8:453-458.
- (2002) J Managed Care Pharm , vol.8 , pp. 453-458
- Gee, M.¹ Hasson, N.K.² Hahn, T.³ Ryono, R.⁴

4
- 0036159125
- Effect of tablet splitting on serum cholesterol concentrations
- Duncan MC, Castle SS, Streetman DS. Effect of tablet splitting on serum cholesterol concentrations. Ann Phamacother 2002; 36:205-209.
- (2002) Ann Phamacother , vol.36 , pp. 205-209
- Duncan, M.C.¹ Castle, S.S.² Streetman, D.S.³

5
- 0037167063
- Accuracy of tablet splitting by elderly patients
- Peek BT, Al-Achi A, Coombs SJ. Accuracy of tablet splitting by elderly patients. JAMA 2002; 399:451-452.
- (2002) JAMA , vol.399 , pp. 451-452
- Peek, B.T.¹ Al-Achi, A.² Coombs, S.J.³

6
- 0031964524
- Accuracy of tablet splitting
- McDevitt JT, Gurst AH, Chen Y. Accuracy of tablet splitting Phamacotherapy 1998; 18:193-197.
- (1998) Phamacotherapy , vol.18 , pp. 193-197
- McDevitt, J.T.¹ Gurst, A.H.² Chen, Y.³

7
- 0024043498
- Broken tablets: Does the sum of the parts equal the whole?
- Gupta P, Gupta K. Broken tablets: does the sum of the parts equal the whole? Am J Health Syst Pharm 1988; 45:1498.
- (1988) Am J Health Syst Pharm , vol.45 , pp. 1498
- Gupta, P.¹ Gupta, K.²

8
- 2942726439
- Tablet splitting: Evaluating appropriateness for patients
- Tablet splitting: evaluating appropriateness for patients. J Am Pharm Assoc 2004; 44:324-325.
- (2004) J Am Pharm Assoc , vol.44 , pp. 324-325

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.